InsidersTradesSigma
Explore the full record of transactions filed by Marek David C, Directeur Exécutif. Director active across 1 companies, notably Myovant Sciences Ltd.. Cumulatively, 4 filings have been published. Total volume traded: €753k. The latest transaction was disclosed on 19 April 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations
David C. Marek serves as Principal Executive Officer of Myovant Sciences Ltd. He leads the company with a strategic vision focused on innovation and operational efficiency. Under his leadership, Myovant Sciences is committed to providing high-quality health solutions. David is recognized for his ability to lead teams toward achieving business objectives.